How to Value a Radiology Practice in 2026

Radiology practice valuation has changed more in the last five years than in the previous twenty. The convergence of private equity consolidation, teleradiology platforms, hospital outsourcing trends, and AI-assisted reading has created a market where the same practice can be worth 6x EBITDA to one buyer and 12x to another. Understanding who those buyers are and what they're paying for is the difference between a good exit and a great one.

I've worked on radiology transactions from four-radiologist community groups to 80-physician regional platforms, and the valuation dynamics differ dramatically at each scale. What follows is how the market actually prices radiology practices in 2026 — not the theoretical framework, but what buyers are writing checks for.

Why Radiology Trades on EBITDA, Not Revenue

Unlike many medical specialties where SDE is the primary valuation metric, radiology practices are almost universally valued on EBITDA. The reason is structural: radiology groups tend to operate as professional corporations with multiple physician-shareholders, making SDE (which assumes a single owner) an awkward fit. EBITDA captures the practice's earning power after normalizing all physician compensation to fair market value.

The current market range is 6-12x EBITDA, with the wide spread reflecting enormous variation in practice characteristics. A four-radiologist group with a single hospital contract and $800K EBITDA might trade at 6-7x. A 25-radiologist platform with diversified contracts, subspecialty coverage, and a teleradiology component might command 10-12x. The premium goes to scale, diversification, and growth trajectory.

Reading Volume and Productivity Metrics

Buyers analyze radiology practices through productivity metrics that don't exist in most other medical specialties. RVUs (relative value units) per radiologist, reads per day, turnaround times, and critical result notification compliance rates all factor into the valuation calculus.

A practice where each radiologist generates 10,000-12,000 professional RVUs annually is operating at market productivity. Below 8,000, and buyers see either underutilization or an aging practice winding down. Above 14,000, and concerns shift to burnout, quality, and sustainability. The sweet spot is consistent productivity in the 10,000-13,000 range with stable or growing volume trends.

Turnaround time is increasingly a competitive differentiator. Hospital clients expect preliminary reads within 30 minutes for emergency studies and final reports within 24 hours for routine exams. Practices that consistently meet or beat these benchmarks retain contracts. Those that don't get replaced — and I've seen it happen with alarming speed. A single lost hospital contract can eliminate 30-40% of a group's revenue overnight.

Subspecialty Coverage Commands a Premium

General diagnostic radiology is a commodity. Subspecialty coverage is not. A practice with fellowship-trained radiologists in neuroradiology, musculoskeletal imaging, interventional radiology, breast imaging, and pediatric radiology can serve academic medical centers and large health systems that a generalist group cannot.

From a valuation standpoint, subspecialty depth does two things. First, it enables higher-acuity contracts that carry better reimbursement rates. A neuroradiology read commands higher professional fees than a routine chest X-ray. Second, it creates switching costs — a hospital that relies on your group for subspecialty coverage can't easily replace you with a teleradiology mill staffed by generalists.

Interventional radiology deserves special mention. Groups with a strong IR practice generate both professional and facility fees, creating a revenue stream that's significantly higher margin than diagnostic-only work. PE buyers have been particularly aggressive in acquiring groups with IR capabilities because the procedure volume is growing and the reimbursement is attractive.

Teleradiology: Platform Value vs. Commodity Risk

Teleradiology is the most polarizing topic in radiology valuation. On one hand, a practice with a proprietary teleradiology platform that serves 15+ hospital clients across multiple states has built something with genuine platform value — potentially 10-12x EBITDA. On the other hand, a practice that depends on teleradiology companies for overflow work is commoditizing its own radiologists.

The practices commanding top multiples in 2026 have invested in their own PACS infrastructure, worklist management systems, and secure connectivity to client facilities. They control the technology stack, which means they control the client relationship. Practices that read through someone else's platform are essentially subcontractors, and they're valued accordingly.

The hybrid model — on-site coverage at anchor hospitals supplemented by teleradiology for after-hours and overflow — is what most acquirers consider optimal. It combines the relationship stickiness of on-site presence with the scalability of remote reading.

Hospital Contract Analysis

Hospital exclusive service agreements are the backbone of most radiology practice revenue. These contracts typically run 3-7 years with renewal options, and their terms dictate everything from coverage requirements to compensation methodology.

Buyers dissect these contracts forensically. The key variables: remaining term and renewal provisions, termination clauses (especially termination without cause provisions), stipend or subsidy arrangements, call coverage requirements, and whether the contract includes technical component revenue or professional only.

Contract concentration is the biggest risk factor I see in radiology transactions. A group that derives 70% of its revenue from a single hospital contract is one RFP cycle away from catastrophe. The groups that trade at 10x+ typically have no single contract representing more than 25% of total revenue, with a diversified mix of hospital, outpatient imaging center, and teleradiology clients.

One nuance that often surprises sellers: the hospital's financial health matters almost as much as your contract terms. A well-run health system with growing volumes is a stable client. A struggling rural hospital that might close or merge creates contract risk that buyers will price into their offer.

AI's Impact on Radiology Valuation

Every radiology practice seller in 2026 faces the AI question, and most handle it poorly. The knee-jerk reaction — "AI will replace radiologists" — is wrong, but the more nuanced reality still affects valuation.

AI tools are augmenting radiologist productivity, not replacing it. Practices that have adopted AI-assisted triage, automated measurements, and preliminary screening tools are seeing 15-25% improvements in reads per day without sacrificing quality. From a buyer's perspective, a practice that has already integrated AI into its workflow demonstrates technological adaptability and has a clearer path to margin expansion.

Practices that have ignored AI entirely face a different calculus. Buyers assume they'll need to invest $200K-$500K in AI infrastructure post-acquisition, and they'll discount accordingly. More importantly, the practice's competitiveness for contract renewals may be at risk if competing groups can offer faster turnaround times powered by AI assistance.

The bottom line on AI: it's a tailwind for radiology practices that embrace it and a headwind for those that don't. Neither scenario justifies a dramatic change in EBITDA multiples, but it can move the needle by 0.5-1.0x in either direction.

The Bottom Line

Radiology practice valuation in 2026 rewards scale, diversification, and technological sophistication. The groups commanding 10-12x EBITDA have 15+ radiologists with subspecialty depth, diversified contract portfolios with no single client exceeding 25% of revenue, proprietary teleradiology infrastructure, and AI-augmented workflows. Smaller groups can still achieve strong exits — 6-8x EBITDA — but need to demonstrate contract stability, physician retention, and a credible growth thesis. If you're considering a sale, start preparing now — the radiology M&A market is active, but buyers are increasingly selective about what they'll pay premium multiples for.